Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 695
Selected: 0
NCT IDTitle
NCT04107051Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence
NCT03172871Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
NCT03158324Phase IIa Dose-Expansion and Biomarker Study of OPB-111077
NCT00463151An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
NCT00948090PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
NCT07184645A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
NCT04038957A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging
NCT00475319Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
NCT00905307Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
NCT00043771Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT01091337Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
NCT02069119A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT00665366Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
NCT01114828A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema
NCT00036101Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
NCT01942148A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT04150146To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers
NCT03141060Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV
NCT05712746Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.
NCT00332241Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT04030143A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT00283179Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
NCT03406286Samsca PMS in ADPKD Patients
NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
NCT01723059Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT02730390Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance
NCT04641780"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
NCT02442778Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
NCT00216749Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT00080314Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
NCT02472652Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT00781638ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT05583474OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
NCT00657176An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
NCT03737474A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
NCT01628926A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT01150162Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation
NCT01349335Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT00993317A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis
NCT03303079Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT04109950A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
NCT01022424A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
NCT03872596Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder